Novartis angling for Chiron buyout
|
DEALS |
|||
|
WHO |
WITH |
WHAT |
SCOOP |
|
Novartis |
Chiron |
$4.5 billion buyout |
Chiron wants more than what Novartis is offering for all the shares it doesn't already own, and analysts think the troubled vaccine maker may just get it. |
|
GlaxoSmithKline |
ID Biomedical |
$1.4 billion buyout |
The deal boosts GSK's role in the flu vaccine business. |
|
Caliper Life Sciences |
NovaScreen Biosciences |
$22 million buyout |
Caliper says the acquisition adds screening, profiling and assay development services, helping make the company a central resource for drug developers. |
|
Barr Pharmaceuticals |
Organon |
Acquisition of oral contraceptive Mircette |
The drug buy paves the way to settle patent litigation surrounding the contraceptive. |
|
Actavis Group |
Higia AD |
Buyout |
Higia is one of the largest drug distributors in Bulgaria. |